Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Drug Safety
|
April 28, 2005
Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme
Mira Harrison-Woolrych, Peter Herbison, Rachael McLean, et al.
Contraception
|
September 29, 2007
Hair loss with use of the levonorgestrel intrauterine device
Helen Paterson, Jennifer Clifton, Dawn Miller, et al.
European Journal of Clinical Pharmacology
|
February 9, 2012
Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres
Mira Harrison-Woolrych, Linda Härmark, Ming Tan, et al.
The Journal of Clinical Psychiatry
|
May 3, 2008
Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases
Susanna E Palmer, Rachael M McLean, Peter M Ellis, et al.
Drug Safety
|
May 24, 2017
The New Phase of ISoP
Sten Olsson, Ian C K Wong, Jean-Christophe Delumeau, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 10, 2011
Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study
Mira Harrison-Woolrych, Keren Skegg, Janelle Ashton, et al.
Drug Safety
|
October 6, 2017
An Update on ISoP Special Interest Groups (SIGs)
Deirdre McCarthy, Priya Bahri, Joanne Barnes, et al.
Drug Safety
|
December 15, 2010
Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centres
Kees van Grootheest, Bernhardt Sachs, Mira Harrison-Woolrych, et al.
Drug Safety
|
June 30, 2020
Evaluation of a Web-Based, 'Purchase Event' Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand
Joanne Barnes, Jane L Sheridan, Christine Yang Dong, et al.
British Journal of Clinical Pharmacology
|
March 18, 2006
QT interval prolongation associated with sibutramine treatment
Mira Harrison-Woolrych, David W J Clark, Geraldine R Hill, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Drug Safety
|
April 28, 2005
Incidence of thrombotic cardiovascular events in patients taking celecoxib compared with those taking rofecoxib: interim results from the New Zealand Intensive Medicines Monitoring Programme
Mira Harrison-Woolrych, Peter Herbison, Rachael McLean, et al.
Contraception
|
September 29, 2007
Hair loss with use of the levonorgestrel intrauterine device
Helen Paterson, Jennifer Clifton, Dawn Miller, et al.
European Journal of Clinical Pharmacology
|
February 9, 2012
Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres
Mira Harrison-Woolrych, Linda Härmark, Ming Tan, et al.
The Journal of Clinical Psychiatry
|
May 3, 2008
Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases
Susanna E Palmer, Rachael M McLean, Peter M Ellis, et al.
Drug Safety
|
May 24, 2017
The New Phase of ISoP
Sten Olsson, Ian C K Wong, Jean-Christophe Delumeau, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
June 10, 2011
Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study
Mira Harrison-Woolrych, Keren Skegg, Janelle Ashton, et al.
Drug Safety
|
October 6, 2017
An Update on ISoP Special Interest Groups (SIGs)
Deirdre McCarthy, Priya Bahri, Joanne Barnes, et al.
Drug Safety
|
December 15, 2010
Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centres
Kees van Grootheest, Bernhardt Sachs, Mira Harrison-Woolrych, et al.
Drug Safety
|
June 30, 2020
Evaluation of a Web-Based, 'Purchase Event' Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand
Joanne Barnes, Jane L Sheridan, Christine Yang Dong, et al.
British Journal of Clinical Pharmacology
|
March 18, 2006
QT interval prolongation associated with sibutramine treatment
Mira Harrison-Woolrych, David W J Clark, Geraldine R Hill, et al.
Page
of 5